Mark Geng

My mission is to positively impact the lives of patients. At Moderna, I work with some of the best scientists in the industry to develop and launch mRNA-based vaccine and therapeutic products.

Previously, I worked on the production and testing of immune-oncology checkmate inhibitors, oncolytic gene therapies, and cardiovascular drugs at BMS. Prior to BMS, I was a study director at a contract research organization under the Merck group. Before Merck, I was a product development lead at a small biotech Parabon. With eight years of industry experience, I have assumed roles in early R&D, CRO, PD, commercialization, late-stage and commercial manufacturing.